Matthew Angel

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Matthew Angel
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Matthew Angel

Form 4 holding CEO and President, Director, 10%+ Owner

Tempest Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
269,621
Estimated value
Report date
04 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO and President, Director, 10%+ Owner

Tempest Therapeutics, Inc.

Security class
Series A Warrant (right to buy)
Shares / value
231,482
Estimated value
Report date
24 Mar 2026
Price
Ownership
By Factor Bioscience Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO and President, Director, 10%+ Owner

Tempest Therapeutics, Inc.

Security class
Series B Warrant (right to buy)
Shares / value
231,482
Estimated value
Report date
24 Mar 2026
Price
Ownership
By Factor Bioscience Inc.
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Eterna Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
132,003
Estimated value
Report date
12 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount

Insider Reports Filed by Matthew Angel

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .